Literature DB >> 16567703

Caudate blood flow and volume are reduced in HIV+ neurocognitively impaired patients.

B M Ances1, A C Roc, J Wang, M Korczykowski, J Okawa, J Stern, J Kim, R Wolf, K Lawler, D L Kolson, J A Detre.   

Abstract

OBJECTIVE: To evaluate the effects of HIV-associated neurocognitive impairment on caudate blood flow and volume.
METHODS: The authors performed continuous arterial spin labeled MRI on 42 HIV+ patients (23 subsyndromic and 19 HIV neurosymptomatic) on highly active antiretroviral therapy and 17 seronegative controls. They compared caudate blood flow and volume among groups.
RESULTS: A stepwise decrease in both caudate blood flow and volume was observed with increasing HIV-associated neurocognitive impairment. Compared with seronegative controls, baseline caudate blood flow was reduced in HIV+ neurosymptomatic patients (p = 0.001) with a similar decreasing trend for subsyndromic HIV+ patients (p = 0.070). Differences in caudate volume were observed only for neurosymptomatic HIV+ patients compared with controls (p = 0.010). A Jonckheere-Terpstra test for trends was significant for both caudate blood flow and volume for each of the three subgroups. Pearson product moment correlation coefficients were not significant between caudate blood flow and volume for each group.
CONCLUSIONS: Decreasing trends in caudate blood flow and volume were associated with significantly increasing HIV-associated neurocognitive impairment (HNCI), with the greatest decreases observed for more severely impaired patients. However, reductions in caudate blood flow and volume were poorly correlated. Changes in residual caudate blood flow may act as a surrogate biomarker for classifying the degree of HNCI.

Entities:  

Mesh:

Year:  2006        PMID: 16567703     DOI: 10.1212/01.wnl.0000203524.57993.e2

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  51 in total

1.  Impact of the HIV Tat C30C31S dicysteine substitution on neuropsychological function in patients with clade C disease.

Authors:  Robert H Paul; John A Joska; Carol Woods; Soraya Seedat; Susan Engelbrecht; Jacqueline Hoare; Jodi Heaps; Victor Valcour; Beau Ances; Laurie M Baker; Lauren E Salminen; Dan J Stein
Journal:  J Neurovirol       Date:  2014-11-01       Impact factor: 2.643

2.  Independent effects of HIV, aging, and HAART on brain volumetric measures.

Authors:  Beau M Ances; Mario Ortega; Florin Vaida; Jodi Heaps; Robert Paul
Journal:  J Acquir Immune Defic Syndr       Date:  2012-04-15       Impact factor: 3.731

3.  Effects of HIV and early life stress on amygdala morphometry and neurocognitive function.

Authors:  Uraina S Clark; Ronald A Cohen; Lawrence H Sweet; Assawin Gongvatana; Kathryn N Devlin; George N Hana; Michelle L Westbrook; Richard C Mulligan; Beth A Jerskey; Tara L White; Bradford Navia; Karen T Tashima
Journal:  J Int Neuropsychol Soc       Date:  2012-05-24       Impact factor: 2.892

4.  Effects of nadir CD4 count and duration of human immunodeficiency virus infection on brain volumes in the highly active antiretroviral therapy era.

Authors:  Ronald A Cohen; Jaroslaw Harezlak; Giovanni Schifitto; George Hana; Uraina Clark; Assawin Gongvatana; Robert Paul; Michael Taylor; Paul Thompson; Jeffery Alger; Mark Brown; Jianhui Zhong; Thomas Campbell; Elyse Singer; Eric Daar; Deborah McMahon; Yuen Tso; Constantin T Yiannoutsos; Bradford Navia
Journal:  J Neurovirol       Date:  2010-02       Impact factor: 2.643

5.  Increased subcortical neural activity among HIV+ individuals during a lexical retrieval task.

Authors:  April D Thames; Philip Sayegh; Kevin Terashima; Jessica M Foley; Andrew Cho; Alyssa Arentoft; Charles H Hinkin; Susan Y Bookheimer
Journal:  Neurobiol Dis       Date:  2015-10-17       Impact factor: 5.996

6.  Measurement of cerebral perfusion with arterial spin labeling: Part 2. Applications.

Authors:  Gregory G Brown; Camellia Clark; Thomas T Liu
Journal:  J Int Neuropsychol Soc       Date:  2007-05       Impact factor: 2.892

Review 7.  Genetic, transcriptomic, and epigenetic studies of HIV-associated neurocognitive disorder.

Authors:  Andrew J Levine; Stella E Panos; Steve Horvath
Journal:  J Acquir Immune Defic Syndr       Date:  2014-04-01       Impact factor: 3.731

8.  HIV-associated neurocognitive disorders and the impact of combination antiretroviral therapies.

Authors:  Beau M Ances; David B Clifford
Journal:  Curr Neurol Neurosci Rep       Date:  2008-11       Impact factor: 5.081

Review 9.  Update on HIV dementia and HIV-associated neurocognitive disorders.

Authors:  Bruce J Brew; Phillip Chan
Journal:  Curr Neurol Neurosci Rep       Date:  2014-08       Impact factor: 5.081

10.  Methamphetamine-induced behavioral sensitization is enhanced in the HIV-1 transgenic rat.

Authors:  Xiangqian Liu; Linda Chang; Michael Vigorito; Marley Kass; He Li; Sulie L Chang
Journal:  J Neuroimmune Pharmacol       Date:  2009-05-15       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.